háttér
Kapcsolat

What is AIPM?

The Association of Innovative Pharmaceutical Manufacturers (AIPM) represents innovative pharmaceutical companies operating in Hungary. Together with our 27 member companies, we work every day to ensure that new, modern medicines and therapies reach Hungarian patients as soon as possible.

The AIPM proudly and actively represents Hungarian interests at the European level and directly brings European industry initiatives to Hungary. The AIPM is a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents nearly 2,000 companies. 

The AIPM office supports the association's strategic planning and operations, providing professional assistance and information to members, and guiding the association's activities.


Board

PAWEL TOKARZEWSKI
PAWEL TOKARZEWSKI
Country Manager, Lilly Hungária
AIPM Board Member
ANIKÓ DESZK
ANIKÓ DESZK
Country Lead, Sanofi Hungary
AIPM Board Member
DR. SÁNDOR LÉVAI
DR. SÁNDOR LÉVAI
General Manager, Takeda Hungary
AIPM Board Member
MASSIMILIANO MAGNELLI
MASSIMILIANO MAGNELLI
General Manager, Bristol Myers Squibb
elnökségi tag
COLETTE MATZ
COLETTE MATZ
General Manager, Novartis Hungary
AIPM Board Member
ANA MARIA VARGAS
ANA MARIA VARGAS
Country Manager, Johnson&Johnson Innovative Medicine
AIPM Board Member

AIPM Staff

Dr. Katalin Szalóki
Dr. Katalin Szalóki
Innovatív Gyógyszergyártók Egyesülete (AIPM)
Igazgató
VERONIKA, KOVÁCS-BORBÁS
VERONIKA, KOVÁCS-BORBÁS
Market Access Manager
DÓRA PAPP
DÓRA PAPP
Alliance Manager
KATA KÁRÁNDI
KATA KÁRÁNDI
Communication Manager
JÚLIA SZILÁGYI
JÚLIA SZILÁGYI
Office manager

AIPM’s vision

Creating a healthcare system that ensures…
...Hungarian people live longer and healthier lives,
...the gap between Hungarian citizens and residents of other European countries in terms of life expectancy and healthy years lived is reduced,
...Hungarian patients have timely access to innovative therapies, and healthcare professionals apply them appropriately.

Our goal is to ensure the right prevention and treatment for the right patient at the right time. Our mission is to communicate and gain recognition among policymakers, organizations, and healthcare professionals shaping the healthcare environment about the vital role innovative medicines play in helping Hungarian people live longer and healthier lives. Additionally, we aim to highlight the significant economic value created by innovative pharmaceutical companies through their activities in Hungary.

Our member companies, in addition to developing innovative medicines, contribute to meeting social needs through collaborations. Our shared goal is to eliminate disparities in healthcare, accelerate patient access to innovative treatments, and enhance the safety of therapies. We work together with various stakeholders in the healthcare sector to develop practical solutions that help achieve these objectives.

Responsibility and transparency

Our member companies not only comply with the inherently strict regulations governing their activities but also set additional requirements for themselves by strengthening self-regulation. They continuously strive to ensure that the activities of innovative pharmaceutical manufacturers remain transparent and ethical at all times.

 

  • Codes of Practice
AIPM Code of Practice 26.05.2020
Ethical Code of Communication 01.06.2022.
EFPIA Code of Practice 26.02.2025.

The disclosure data of our member companies can be accessed by clicking on the logos below.

AbbVie Kft.
Amgen Gyógyszerkereskedelmi Kft.
Angelini Pharama
Astellas Pharma Kft.
AstraZeneca Kft.
Bayer Hungária Kft.
Berlin-Chemie/A. Menarini Kft.
Biogen Idec Hungary Kft.
Brystol-Myers Squibb
Chiesi Hungary Kft.
Boehringer Ingelheim
IBSA Pharma Kft.
IPSEN Pharma Hungary Kft.
Janssen-Cilag Kft. - Johnson&Johnson
Lilly Hungária Kft.
Lundbeck Hungária Kft.
Merck Kft.
MSD Pharma Hungary Kft.
Novartis Hungária Kft.
Novo Nordisk Hungária Kft.
Pfizer Gyógyszerkereskedelmi Kft.
Roche (Magyarország) Kft.
Sanofi-Aventis Zrt.
Servier Hungária Kft.
SOBI Swedidh Orphan Biovitrum s.r.o.
Takeda Pharma Kft.
UCB Magyarország Kft.

More news